FY2027 · effective Oct 1, 2026 – Sep 30, 2027
ICD-10-CM FY2027 code changes
FY2027, effective October 1, 2026 through September 30, 2027, adds 238 codes (190 billable), deletes 21 codes (15 billable), turns 15 billable codes into headers and revises 4 titles. Billable codes went from 74,719 in FY2026 to 74,879.
Every count on this page comes from comparing the NCHS order files of FY2026 and FY2027 line by line; titles are printed as in those files. The categories with the most new billable codes: T52 (36), O31 (28), M86 (24), O00 (16), T59 (12).
Billable codes
74,719 → 74,879
Other editions
FY2027 is the edition in effect; earlier editions are not on this site.
- Codes added
- +238
- New billable
- 190
- Deleted
- 21
- Now headers
- 15
- Titles revised
- 4
- POA list
- +62 / −12
New codes (238)
“Previous assignment” is the code that covered the condition before, from the NCHS conversion table.
| Code | Title (NCHS) | Status | Previous assignment |
|---|---|---|---|
| C78.31 | Secondary malignant neoplasm of larynx | Billable | C78.39 |
| C78.32 | Secondary malignant neoplasm of pharynx | Billable | C78.39 |
| C79.83 | Secondary malignant neoplasm of oral cavity | Billable | C79.89 |
| D69.11 | Glanzmann thrombasthenia | Billable | D69.1 |
| D69.19 | Other qualitative platelet defects | Billable | D69.1 |
| E89.83 | Postprocedural hypoglycemia following a procedure | Header | – |
| E89.830 | Post bariatric hypoglycemia | Billable | E89.89 |
| E89.838 | Other postprocedural hypoglycemia | Billable | E89.89 |
| F64.A | Gender identity disorder, in remission | Billable | F64.9 |
| I42.00 | Dilated cardiomyopathy, unspecified | Billable | I42.0 |
| I42.01 | Familial-genetic dilated cardiomyopathy | Billable | I42.0 |
| I42.09 | Other dilated cardiomyopathy | Billable | I42.0 |
| I42.81 | Arrhythmogenic cardiomyopathy | Billable | I42.8 |
| I42.89 | Other cardiomyopathies not elsewhere classified | Billable | I42.8 |
| I47.22 | Catecholaminergic polymorphic ventricular tachycardia [CPVT] | Billable | I47.29 |
| I49.81 | Brugada syndrome | Billable | I49.8 |
| I49.82 | Ventricular bigeminy | Billable | I49.8 |
| I49.89 | Other specified cardiac arrhythmias not elsewhere classified | Billable | I49.8 |
| J34.83 | Odontogenic sinusitis | Header | – |
| J34.830 | Odontogenic sinusitis, maxillary sinus | Billable | J34.89 |
| J34.831 | Odontogenic sinusitis, ethmoid sinus | Billable | J34.89 |
| J34.832 | Odontogenic sinusitis, frontal sinus | Billable | J34.89 |
| J34.833 | Odontogenic sinusitis, sphenoid sinus | Billable | J34.89 |
| J34.839 | Odontogenic sinusitis, unspecified | Billable | J34.89 |
| J4B | Pulmonary mycetoma | Billable | B47.- and J98.8, B37.1, B38.0, B38.1, B38.2, B44.1 |
| K31.B | Hypertrophic pyloric stenosis, in childhood | Billable | Q40.0 |
| K6A | Diseases of the pelvis, not elsewhere classified | Header | – |
| K6A.0 | Pelvic abscess | Header | – |
| K6A.01 | Prevesical abscess | Billable | K68.19 |
| K6A.09 | Other pelvic abscess | Billable | K68.19 and K65.1 |
| K6A.8 | Other diseases of the pelvis, not elsewhere classified | Billable | K92.89, N39.8, N50.89, N94.89, R68.89 |
| K74.0A | Hepatic fibrosis, moderate fibrosis | Billable | K74.01 |
| K76.83 | Intestinal failure-associated liver disease | Billable | K90.83 |
| L02.237 | Carbuncle of flank | Billable | L02.232 |
| M04.3 | VEXAS syndrome | Billable | M04.8 |
| M67.A | Plantar fasciitis | Header | – |
| M67.A0 | Plantar fasciitis, foot | Header | – |
| M67.A01 | Plantar fasciitis, right foot | Billable | M72.2 |
| M67.A02 | Plantar fasciitis, left foot | Billable | M72.2 |
| M67.A09 | Plantar fasciitis, unspecified foot | Billable | M72.2 |
| M72.20 | Plantar fascial fibromatosis, unspecified foot | Billable | M72.2 |
| M72.21 | Plantar fascial fibromatosis, right foot | Billable | M72.2 |
| M72.22 | Plantar fascial fibromatosis, left foot | Billable | M72.2 |
| M86.8X11 | Other osteomyelitis, right shoulder | Billable | M86.8X1 |
| M86.8X12 | Other osteomyelitis, left shoulder | Billable | M86.8X1 |
| M86.8X19 | Other osteomyelitis, unspecified shoulder | Billable | M86.8X1 |
| M86.8X21 | Other osteomyelitis, right upper arm | Billable | M86.8X2 |
| M86.8X22 | Other osteomyelitis, left upper arm | Billable | M86.8X2 |
| M86.8X29 | Other osteomyelitis, unspecified upper arm | Billable | M86.8X2 |
| M86.8X31 | Other osteomyelitis, right forearm | Billable | M86.8X3 |
| M86.8X32 | Other osteomyelitis, left forearm | Billable | M86.8X3 |
| M86.8X39 | Other osteomyelitis, unspecified forearm | Billable | M86.8X3 |
| M86.8X41 | Other osteomyelitis, right hand | Billable | M86.8X4 |
| M86.8X42 | Other osteomyelitis, left hand | Billable | M86.8X4 |
| M86.8X49 | Other osteomyelitis, unspecified hand | Billable | M86.8X4 |
| M86.8X51 | Other osteomyelitis, right thigh | Billable | M86.8X5 |
| M86.8X52 | Other osteomyelitis, left thigh | Billable | M86.8X5 |
| M86.8X59 | Other osteomyelitis, unspecified thigh | Billable | M86.8X5 |
| M86.8X61 | Other osteomyelitis, right lower leg | Billable | M86.8X6 |
| M86.8X62 | Other osteomyelitis, left lower leg | Billable | M86.8X6 |
| M86.8X69 | Other osteomyelitis, unspecified lower leg | Billable | M86.8X6 |
| M86.8X71 | Other osteomyelitis, right ankle and foot | Billable | M86.8X7 |
| M86.8X72 | Other osteomyelitis, left ankle and foot | Billable | M86.8X7 |
| M86.8X79 | Other osteomyelitis, unspecified ankle and foot | Billable | M86.8X7 |
| M86.8X80 | Other osteomyelitis, skull | Billable | M86.8X8 |
| M86.8X81 | Other osteomyelitis, face and sinuses | Billable | M86.8X8 |
| M86.8X89 | Other osteomyelitis, other site | Billable | M86.8X8 |
| N99.86 | Intraoperative and postprocedural complications and disorders of breast | Header | – |
| N99.860 | Intraoperative and postprocedural nipple ischemia | Billable | N99.89 |
| N99.861 | Intraoperative and postprocedural nipple necrosis | Billable | N99.89 |
| O00.12 | Interstitial ectopic pregnancy without intrauterine pregnancy | Header | – |
| O00.121 | Right interstitial ectopic pregnancy without intrauterine pregnancy | Billable | O00.101 |
| O00.122 | Left interstitial ectopic pregnancy without intrauterine pregnancy | Billable | O00.102 |
| O00.129 | Unspecified interstitial ectopic pregnancy without intrauterine pregnancy | Billable | O00.109 |
| O00.13 | Interstitial ectopic pregnancy with intrauterine pregnancy | Header | – |
| O00.131 | Right interstitial ectopic pregnancy with intrauterine pregnancy | Billable | O00.111 |
| O00.132 | Left interstitial ectopic pregnancy with intrauterine pregnancy | Billable | O00.112 |
| O00.139 | Unspecified interstitial ectopic pregnancy with intrauterine pregnancy | Billable | O00.119 |
| O00.3 | Cesarean scar ectopic pregnancy | Header | – |
| O00.31 | Cesarean scar ectopic pregnancy without intrauterine pregnancy | Billable | O00.80 |
| O00.32 | Cesarean scar ectopic pregnancy with intrauterine pregnancy | Billable | O00.81 |
| O00.4 | Cervical ectopic pregnancy | Header | – |
| O00.41 | Cervical ectopic pregnancy without intrauterine pregnancy | Billable | O00.80 |
| O00.42 | Cervical ectopic pregnancy with intrauterine pregnancy | Billable | O00.81 |
| O00.5 | Cornual ectopic pregnancy | Header | – |
| O00.51 | Cornual ectopic pregnancy without intrauterine pregnancy | Header | – |
| O00.511 | Right cornual ectopic pregnancy without intrauterine pregnancy | Billable | O00.80 |
| O00.512 | Left cornual ectopic pregnancy without intrauterine pregnancy | Billable | O00.80 |
| O00.519 | Unspecified cornual ectopic pregnancy without intrauterine pregnancy | Billable | O00.80 |
| O00.52 | Cornual ectopic pregnancy with intrauterine pregnancy | Header | – |
| O00.521 | Right cornual ectopic pregnancy with intrauterine pregnancy | Billable | O00.81 |
| O00.522 | Left cornual ectopic pregnancy with intrauterine pregnancy | Billable | O00.81 |
| O00.529 | Unspecified cornual ectopic pregnancy with intrauterine pregnancy | Billable | O00.81 |
| O31.4 | Continuing pregnancy after vanishing twin syndrome of one fetus or more | Header | – |
| O31.40 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester | Header | – |
| O31.40X0 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, not applicable or unspecified | Billable | O31.8X90 |
| O31.40X1 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 1 | Billable | O31.8X91 |
| O31.40X2 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 2 | Billable | O31.8X92 |
| O31.40X3 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 3 | Billable | O31.8X93 |
| O31.40X4 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 4 | Billable | O31.8X94 |
| O31.40X5 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 5 | Billable | O31.8X95 |
| O31.40X9 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, other fetus | Billable | O31.8X99 |
| O31.41 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester | Header | – |
| O31.41X0 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, not applicable or unspecified | Billable | O31.8X10 |
| O31.41X1 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 1 | Billable | O31.8X11 |
| O31.41X2 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 2 | Billable | O31.8X12 |
| O31.41X3 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 3 | Billable | O31.8X13 |
| O31.41X4 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 4 | Billable | O31.8X14 |
| O31.41X5 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 5 | Billable | O31.8X15 |
| O31.41X9 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, other fetus | Billable | O31.8X19 |
| O31.42 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester | Header | – |
| O31.42X0 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, not applicable or unspecified | Billable | O31.8X20 |
| O31.42X1 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 1 | Billable | O31.8X21 |
| O31.42X2 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 2 | Billable | O31.8X22 |
| O31.42X3 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 3 | Billable | O31.8X23 |
| O31.42X4 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 4 | Billable | O31.8X24 |
| O31.42X5 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 5 | Billable | O31.8X25 |
| O31.42X9 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, other fetus | Billable | O31.8X29 |
| O31.43 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester | Header | – |
| O31.43X0 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, not applicable or unspecified | Billable | O31.8X30 |
| O31.43X1 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 1 | Billable | O31.8X31 |
| O31.43X2 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 2 | Billable | O31.8X32 |
| O31.43X3 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 3 | Billable | O31.8X33 |
| O31.43X4 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 4 | Billable | O31.8X34 |
| O31.43X5 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 5 | Billable | O31.8X35 |
| O31.43X9 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, other fetus | Billable | O31.8X39 |
| Q87.A | Loeys-Dietz syndrome | Billable | Q87.89 |
| QA1 | Genetic disorders associated with neoplasms, not elsewhere classified | Header | – |
| QA1.7 | Inherited neoplasm predisposition syndromes involving multiple systems, not elsewhere classified | Header | – |
| QA1.71 | Lynch syndrome | Billable | Z15.09 |
| QA1.79 | Other inherited neoplasm predisposition syndrome of multiple systems | Header | – |
| QA1.790 | Familial cancer syndrome with pathogenic BRCA1 mutation | Billable | Z15.09 |
| QA1.791 | Familial cancer syndrome with pathogenic BRCA2 mutation | Billable | Z15.09 |
| QA1.792 | Li Fraumeni syndrome | Billable | Z15.09 |
| QA1.798 | Other inherited neoplasm predisposition syndrome of multiple systems | Billable | Z15.09 |
| R78.72 | Abnormal gadolinium level in blood | Billable | R78.79 |
| T52.81 | Toxic effects of alkenes | Header | – |
| T52.811 | Toxic effect of alkenes, accidental (unintentional) | Header | – |
| T52.811A | Toxic effect of alkenes, accidental (unintentional), initial encounter | Billable | T52.8X1A |
| T52.811D | Toxic effect of alkenes, accidental (unintentional), subsequent encounter | Billable | T52.8X1D |
| T52.811S | Toxic effect of alkenes, accidental (unintentional), sequela | Billable | T52.8X1S |
| T52.812 | Toxic effect of alkenes, intentional self-harm | Header | – |
| T52.812A | Toxic effect of alkenes, intentional self-harm, initial encounter | Billable | T52.8X2A |
| T52.812D | Toxic effect of alkenes, intentional self-harm, subsequent encounter | Billable | T52.8X2D |
| T52.812S | Toxic effect of alkenes, intentional self-harm, sequela | Billable | T52.8X2S |
| T52.813 | Toxic effect of alkenes, assault | Header | – |
| T52.813A | Toxic effect of alkenes, assault, initial encounter | Billable | T52.8X3A |
| T52.813D | Toxic effect of alkenes, assault, subsequent encounter | Billable | T52.8X3D |
| T52.813S | Toxic effect of alkenes, assault, sequela | Billable | T52.8X3S |
| T52.814 | Toxic effect of alkenes, undetermined | Header | – |
| T52.814A | Toxic effect of alkenes, undetermined, initial encounter | Billable | T52.8X4A |
| T52.814D | Toxic effect of alkenes, undetermined, subsequent encounter | Billable | T52.8X4D |
| T52.814S | Toxic effect of alkenes, undetermined, sequela | Billable | T52.8X4S |
| T52.82 | Toxic effects of cycloparaffins | Header | – |
| T52.821 | Toxic effect of cycloparaffins, accidental (unintentional) | Header | – |
| T52.821A | Toxic effect of cycloparaffins, accidental (unintentional), initial encounter | Billable | T52.8X1A |
| T52.821D | Toxic effect of cycloparaffins, accidental (unintentional), subsequent encounter | Billable | T52.8X1D |
| T52.821S | Toxic effect of cycloparaffins, accidental (unintentional), sequela | Billable | T52.8X1S |
| T52.822 | Toxic effect of cycloparaffins, intentional self-harm | Header | – |
| T52.822A | Toxic effect of cycloparaffins, intentional self-harm, initial encounter | Billable | T52.8X2A |
| T52.822D | Toxic effect of cycloparaffins, intentional self-harm, subsequent encounter | Billable | T52.8X2D |
| T52.822S | Toxic effect of cycloparaffins, intentional self-harm, sequela | Billable | T52.8X2S |
| T52.823 | Toxic effect of cycloparaffins, assault | Header | – |
| T52.823A | Toxic effect of cycloparaffins, assault, initial encounter | Billable | T52.8X3A |
| T52.823D | Toxic effect of cycloparaffins, assault, subsequent encounter | Billable | T52.8X3D |
| T52.823S | Toxic effect of cycloparaffins, assault, sequela | Billable | T52.8X3S |
| T52.824 | Toxic effect of cycloparaffins, undetermined | Header | – |
| T52.824A | Toxic effect of cycloparaffins, undetermined, initial encounter | Billable | T52.8X4A |
| T52.824D | Toxic effect of cycloparaffins, undetermined, subsequent encounter | Billable | T52.8X4D |
| T52.824S | Toxic effect of cycloparaffins, undetermined, sequela | Billable | T52.8X4S |
| T52.89 | Toxic effects of other organic solvents | Header | – |
| T52.891 | Toxic effect of other organic solvents, accidental (unintentional) | Header | – |
| T52.891A | Toxic effect of other organic solvents, accidental (unintentional), initial encounter | Billable | T52.8X1A |
| T52.891D | Toxic effect of other organic solvents, accidental (unintentional), subsequent encounter | Billable | T52.8X1D |
| T52.891S | Toxic effect of other organic solvents, accidental (unintentional), sequela | Billable | T52.8X1S |
| T52.892 | Toxic effect of other organic solvents, intentional self-harm | Header | – |
| T52.892A | Toxic effect of other organic solvents, intentional self-harm, initial encounter | Billable | T52.8X2A |
| T52.892D | Toxic effect of other organic solvents, intentional self-harm, subsequent encounter | Billable | T52.8X2D |
| T52.892S | Toxic effect of other organic solvents, intentional self-harm, sequela | Billable | T52.8X2S |
| T52.893 | Toxic effect of other organic solvents, assault | Header | – |
| T52.893A | Toxic effect of other organic solvents, assault, initial encounter | Billable | T52.8X3A |
| T52.893D | Toxic effect of other organic solvents, assault, subsequent encounter | Billable | T52.8X3D |
| T52.893S | Toxic effect of other organic solvents, assault, sequela | Billable | T52.8X3S |
| T52.894 | Toxic effect of other organic solvents, undetermined | Header | – |
| T52.894A | Toxic effect of other organic solvents, undetermined, initial encounter | Billable | T52.8X4A |
| T52.894D | Toxic effect of other organic solvents, undetermined, subsequent encounter | Billable | T52.8X4D |
| T52.894S | Toxic effect of other organic solvents, undetermined, sequela | Billable | T52.8X4S |
| T59.82 | Toxic effects of hexamethylene diisocyanate | Header | – |
| T59.821 | Toxic effect of hexamethylene diisocyanate, accidental (unintentional) | Header | – |
| T59.821A | Toxic effect of hexamethylene diisocyanate, accidental (unintentional), initial encounter | Billable | T59.891A |
| T59.821D | Toxic effect of hexamethylene diisocyanate, accidental (unintentional), subsequent encounter | Billable | T59.891D |
| T59.821S | Toxic effect of hexamethylene diisocyanate, accidental (unintentional), sequela | Billable | T59.891S |
| T59.822 | Toxic effect of hexamethylene diisocyanate, intentional self-harm | Header | – |
| T59.822A | Toxic effect of hexamethylene diisocyanate, intentional self-harm, initial encounter | Billable | T59.892A |
| T59.822D | Toxic effect of hexamethylene diisocyanate, intentional self-harm, subsequent encounter | Billable | T59.892D |
| T59.822S | Toxic effect of hexamethylene diisocyanate, intentional self-harm, sequela | Billable | T59.892S |
| T59.823 | Toxic effect of hexamethylene diisocyanate, assault | Header | – |
| T59.823A | Toxic effect of hexamethylene diisocyanate, assault, initial encounter | Billable | T59.893A |
| T59.823D | Toxic effect of hexamethylene diisocyanate, assault, subsequent encounter | Billable | T59.893D |
| T59.823S | Toxic effect of hexamethylene diisocyanate, assault, sequela | Billable | T59.893S |
| T59.824 | Toxic effect of hexamethylene diisocyanate, undetermined | Header | – |
| T59.824A | Toxic effect of hexamethylene diisocyanate, undetermined, initial encounter | Billable | T59.894A |
| T59.824D | Toxic effect of hexamethylene diisocyanate, undetermined, subsequent encounter | Billable | T59.894D |
| T59.824S | Toxic effect of hexamethylene diisocyanate, undetermined, sequela | Billable | T59.894S |
| T65.85 | Toxic effect of medetomidine | Header | – |
| T65.851 | Toxic effect of medetomidine, accidental (unintentional) | Header | – |
| T65.851A | Toxic effect of medetomidine, accidental (unintentional), initial encounter | Billable | T65.891A |
| T65.851D | Toxic effect of medetomidine, accidental (unintentional), subsequent encounter | Billable | T65.891D |
| T65.851S | Toxic effect of medetomidine, accidental (unintentional), sequela | Billable | T65.891S |
| T65.852 | Toxic effect of medetomidine, intentional self-harm | Header | – |
| T65.852A | Toxic effect of medetomidine, intentional self-harm, initial encounter | Billable | T65.892A |
| T65.852D | Toxic effect of medetomidine, intentional self-harm, subsequent encounter | Billable | T65.892D |
| T65.852S | Toxic effect of medetomidine, intentional self-harm, sequela | Billable | T65.892S |
| T65.853 | Toxic effect of medetomidine, assault | Header | – |
| T65.853A | Toxic effect of medetomidine, assault, initial encounter | Billable | T65.893A |
| T65.853D | Toxic effect of medetomidine, assault, subsequent encounter | Billable | T65.893D |
| T65.853S | Toxic effect of medetomidine, assault, sequela | Billable | T65.893S |
| T65.854 | Toxic effect of medetomidine, undetermined | Header | – |
| T65.854A | Toxic effect of medetomidine, undetermined, initial encounter | Billable | T65.894A |
| T65.854D | Toxic effect of medetomidine, undetermined, subsequent encounter | Billable | T65.894D |
| T65.854S | Toxic effect of medetomidine, undetermined, sequela | Billable | T65.894S |
| Z68.18 | Body mass index [BMI] 18.4 or less, adult | Billable | Z68.1 |
| Z68.19 | Body mass index [BMI] 18.5-19.9, adult | Billable | Z68.1 |
| Z77.013 | Contact with and (suspected) exposure to gadolinium | Billable | Z77.018 |
| Z77.32 | Contact with and (suspected) exposure to burn pits in war theater | Billable | Z77.39 |
| Z77.33 | Contact with and (suspected) exposure to Agent Orange | Billable | Z77.39 |
| Z77.4 | Contact with and (suspected) exposure to blast overpressure | Header | – |
| Z77.40 | Contact with and (suspected) exposure to unspecified blast overpressure | Billable | Z77.9 |
| Z77.41 | Contact with and (suspected) exposure to low-level blast overpressure | Billable | Z77.9 |
| Z77.42 | Contact with and (suspected) exposure to high-level blast overpressure | Billable | Z77.9 |
| Z77.49 | Contact with and (suspected) exposure to other blast overpressure | Billable | Z77.9 |
| Z86.17 | Personal history of Clostridioides difficile infection | Billable | Z86.19 |
| Z87.8901 | Personal history of social gender transition | Billable | Z87.890 |
| Z87.8902 | Personal history of medical gender transition | Billable | Z87.890 |
| Z87.8903 | Personal history of surgical gender transition | Billable | Z87.890 |
| Z87.8904 | Personal history of intersex surgery | Billable | Z87.890 |
| Z87.8909 | Personal history of unspecified gender transition | Billable | Z87.890 |
| Z87.893 | Personal history of gender detransition | Billable | Z87.898 |
Billable in FY2026, header in FY2027 (15)
A claim with one of these codes is now incomplete: each one heads more specific codes.
| Code | Title (NCHS) | Billable codes below |
|---|---|---|
| D69.1 | Qualitative platelet defects | 2 |
| I42.0 | Dilated cardiomyopathy | 3 |
| I42.8 | Other cardiomyopathies | 2 |
| I49.8 | Other specified cardiac arrhythmias | 3 |
| M72.2 | Plantar fascial fibromatosis | 3 |
| M86.8X1 | Other osteomyelitis, shoulder | 3 |
| M86.8X2 | Other osteomyelitis, upper arm | 3 |
| M86.8X3 | Other osteomyelitis, forearm | 3 |
| M86.8X4 | Other osteomyelitis, hand | 3 |
| M86.8X5 | Other osteomyelitis, thigh | 3 |
| M86.8X6 | Other osteomyelitis, lower leg | 3 |
| M86.8X7 | Other osteomyelitis, ankle and foot | 3 |
| M86.8X8 | Other osteomyelitis, other site | 3 |
| Z68.1 | Body mass index [BMI] 19.9 or less, adult | 2 |
| Z87.890 | Personal history of sex reassignment | 5 |
Deleted codes (21)
Titles as they stood in the FY2026 order file.
| Code | FY2026 title (NCHS) | FY2026 status |
|---|---|---|
| S23.420 | Sprain of sternoclavicular (joint) (ligament) | Header |
| S23.420A | Sprain of sternoclavicular (joint) (ligament), initial encounter | Billable |
| S23.420D | Sprain of sternoclavicular (joint) (ligament), subsequent encounter | Billable |
| S23.420S | Sprain of sternoclavicular (joint) (ligament), sequela | Billable |
| T52.8X | Toxic effects of other organic solvents | Header |
| T52.8X1 | Toxic effect of other organic solvents, accidental (unintentional) | Header |
| T52.8X1A | Toxic effect of other organic solvents, accidental (unintentional), initial encounter | Billable |
| T52.8X1D | Toxic effect of other organic solvents, accidental (unintentional), subsequent encounter | Billable |
| T52.8X1S | Toxic effect of other organic solvents, accidental (unintentional), sequela | Billable |
| T52.8X2 | Toxic effect of other organic solvents, intentional self-harm | Header |
| T52.8X2A | Toxic effect of other organic solvents, intentional self-harm, initial encounter | Billable |
| T52.8X2D | Toxic effect of other organic solvents, intentional self-harm, subsequent encounter | Billable |
| T52.8X2S | Toxic effect of other organic solvents, intentional self-harm, sequela | Billable |
| T52.8X3 | Toxic effect of other organic solvents, assault | Header |
| T52.8X3A | Toxic effect of other organic solvents, assault, initial encounter | Billable |
| T52.8X3D | Toxic effect of other organic solvents, assault, subsequent encounter | Billable |
| T52.8X3S | Toxic effect of other organic solvents, assault, sequela | Billable |
| T52.8X4 | Toxic effect of other organic solvents, undetermined | Header |
| T52.8X4A | Toxic effect of other organic solvents, undetermined, initial encounter | Billable |
| T52.8X4D | Toxic effect of other organic solvents, undetermined, subsequent encounter | Billable |
| T52.8X4S | Toxic effect of other organic solvents, undetermined, sequela | Billable |
Revised titles (4)
| Code | FY2026 title | FY2027 title |
|---|---|---|
| L02.232 | Carbuncle of back [any part, except buttock] | Carbuncle of back [any part, except buttock and flank] |
| L03.312 | Cellulitis of back [any part except buttock] | Cellulitis of back [any part except buttock and flank] |
| L03.322 | Acute lymphangitis of back [any part except buttock] | Acute lymphangitis of back [any part except buttock and flank] |
| Z29.14 | Encounter for prophylactic rabies immune globin | Encounter for prophylactic rabies immune globulin |
POA exempt list
The FY2027 list of codes exempt from present-on-admission reporting has 38,399 codes. Compared with the previous list, NCHS added 62 codes and removed 12 codes.
Added: Q87.A, QA1.71, QA1.790, QA1.791, QA1.792, QA1.798, T52.811D, T52.811S, T52.812D, T52.812S, T52.813D, T52.813S, T52.814D, T52.814S, T52.821D, T52.821S, T52.822D, T52.822S, T52.823D, T52.823S, T52.824D, T52.824S, T52.891D, T52.891S, T52.892D, T52.892S, T52.893D, T52.893S, T52.894D, T52.894S, T59.821D, T59.821S, T59.822D, T59.822S, T59.823D, T59.823S, T59.824D, T59.824S, T65.851D, T65.851S, T65.852D, T65.852S, T65.853D, T65.853S, T65.854D, T65.854S, Z68.18, Z68.19, Z77.013, Z77.32, Z77.33, Z77.40, Z77.41, Z77.42, Z77.49, Z86.17, Z87.8901, Z87.8902, Z87.8903, Z87.8904, Z87.8909, Z87.893
Removed: S23.420D, S23.420S, T52.8X1D, T52.8X1S, T52.8X2D, T52.8X2S, T52.8X3D, T52.8X3S, T52.8X4D, T52.8X4S, Z68.1, Z87.890